Drug · DIN 02137984
TALWIN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since February 19, 2021; first marketed December 31, 1970.
- Drug Identification Number (DIN)
- 02137984
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Narcotics (cdsa i)
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Pentazocine N02AD01
- Class
- Human
- Record last updated
- June 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PENTAZOCINE (PENTAZOCINE HYDROCHLORIDE) | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 29, 2006: NOC 7848New Drug Submission (NDS) · Manufacturer name change
- November 2, 2000: NOC 1378New Drug Submission (NDS)
Other DINs named TALWIN
- DIN 02241976 · Cancelled Post Market